BioNTech (ADRs) Aktie
100,60
EUR
+4,45
EUR
+4,63
%
106,13
USD
+4,25
USD
+4,17
%
BioNTech (ADRs) Aktie Analyse
| 15.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 05.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 02.10.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 18.09.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 16.09.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 13.09.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 16.08.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 06.08.24 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 05.08.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 24.05.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 10.05.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 08.05.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 07.05.24 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 06.05.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 23.04.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 22.03.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 20.03.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 20.03.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 09.01.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 14.12.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 12.12.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 28.11.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 08.11.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 07.11.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 30.10.23 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 16.10.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 06.09.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 01.09.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 18.08.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 08.08.23 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 07.08.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 06.06.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 05.06.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 18.05.23 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 10.05.23 | BioNTech (ADRs) Equal-weight | Morgan Stanley | |
| 09.05.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 08.05.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 26.04.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 24.04.23 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 28.03.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 28.03.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 01.02.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 16.01.23 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 11.01.23 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 21.11.22 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 15.11.22 | BioNTech (ADRs) Neutral | UBS AG | |
| 08.11.22 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 24.10.22 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |